| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 7 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | United States | 5 | |
| #4 | Australia | 4 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks | |
| #5 | Organic fine chemistry | |
| #6 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Microorganisms | |
| #5 | Analysing materials | |
| #6 | Enzymes | |
| #7 | Heterocyclic compounds | |
| #8 | Unspecified technologies | |
| #9 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Feldmann Heinz | 6 |
| #2 | Jones Steven | 6 |
| #3 | Stroeher Ute | 5 |
| #4 | Van Domselaar Gary | 4 |
| #5 | Luo Ma | 4 |
| #6 | Li Xuguang | 4 |
| #7 | Kobinger Gary | 3 |
| #8 | Qui Xiangguo | 3 |
| #9 | Patel Ami | 3 |
| #10 | He Runtao | 3 |
| Publication | Filing date | Title |
|---|---|---|
| EP3787663A1 | Poxvirus host range protein k3 as a positive selection marker for generation of recombinant poxviruses, a therapeutic target for poxvirus infection and a therapeutic agent for pkr related diseases | |
| EP3713600A1 | Synthetic hemagglutinin as universal vaccine against infection by type b influenza viruses (ibv) | |
| EP2694654A1 | Protease cleavage site peptides as an hiv vaccine | |
| CA2761733A1 | Reagents and methods for detecting influenza virus proteins | |
| EP3048115A2 | Monoclonal antibodies for ebola and marburg viruses | |
| CA2652103A1 | Anthrax vaccine | |
| AU2004229597A1 | SARS-related proteins |